Acer Therapeutics Q2 EPS $(0.23) Up From $(0.56) YoY

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.23) per share. This is a 58.93 percent increase over losses of $(0.56) per share from the same period last year.

byBenzinga Newsdesk

August 10, 2021

1 minute read

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.23) per share. This is a 58.93 percent increase over losses of $(0.56) per share from the same period last year.

Earnings

Recap: Invitae Q1 Earnings

By Benzinga Insights

Today, 4:27 AM

Invitae (NYSE:NVTA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Invitae missed estimated earnings by 2.63%, reporting an EPS of $-0.78 versus an estimate of $-0.76.

NVTA

Hub Group Q3 EPS $1.28 Beats $1.10 Estimate, Sales $1.07B Miss $1.09B Estimate

By Bill Haddad

Today, 4:27 AM

Hub Group (NASDAQ:HUBG) reported quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $1.10 by 16.36 percent. This is a 72.97 percent increase over earnings of $0.74 per share from the same

HUBG

New York Beige Book: The regional economy continued to grow at a strong pace, with growth broad-based across industries. Hiring picked up and wages continued to grow moderately, with availability of workers cited as a top concern.

By Benzinga Newsdesk

Today, 4:27 AM

New York The regional economy continued to grow at a strong pace, with growth broad-based across industries. Hiring picked up and wages continued to grow moderately, with availability of workers cited as a top concern.

SPY